Published • loading... • Updated
It's Not Too Late to Get Vaccinated This Respiratory Season
Vaccines reduce hospitalizations and severe outcomes from flu, COVID-19, RSV, and pneumococcal disease, experts say, urging vaccination during the 2025-2026 respiratory season.
- This respiratory season, the National Foundation for Infectious Diseases and healthcare professionals urge vaccination, stressing it’s not too late to protect against influenza, COVID-19, RSV and pneumococcal disease.
- Because vaccines lower severe outcomes, vaccination is the most effective way to prevent severe disease outcomes and can make illness milder while reducing missed work or school and easing health-care system strain.
- Regulators note that recommended vaccines undergo extensive regulatory safety testing and ongoing monitoring, and common side effects are normal immune responses and rare.
- Because coverage can vary, note that federal recommendations impact availability and coverage while state governments and insurance companies develop their own rules; if barriers arise, talk with a trusted healthcare professional.
- Specific guidance notes that updated COVID-19 vaccine is recommended for high-risk groups and pneumococcal vaccination for children younger than 5 and adults 50 and older, with resources on the National Foundation for Infectious Diseases website for the 2025-2026 season.
Insights by Ground AI
66 Articles
66 Articles
+65 Reposted by 65 other sources
It's Not Too Late to Get Vaccinated This Respiratory Season
(StatePoint) In a time of confusion and inconsistent information, healthcare professionals want you to know that it’s not too late to get vaccinated this respiratory season. Getting vaccinated helps protect against potentially serious diseases like influenza (flu), COVID-19, respiratory syncytial…
·Billings, United States
Read Full ArticleCoverage Details
Total News Sources66
Leaning Left7Leaning Right4Center23Last UpdatedBias Distribution68% Center
Bias Distribution
- 68% of the sources are Center
68% Center
L 20%
C 68%
12%
Factuality
To view factuality data please Upgrade to Premium


















